معرفی
Dr. John Southern is an Assistant Professor in the Department of Chemistry at Trinity College Dublin (TCD), where he conducts research at the intersection of organic, medicinal, and chemical biology. His work focuses on the synthesis of novel nucleobase analogs and small molecules with therapeutic potential for autoimmune and neuroinflammatory diseases.
- Assistant Professor, Department of Chemistry, Trinity College Dublin
- Visiting Professor, Louvain-la-Neuve University, Belgium (2006)
His research interests include medicinal chemistry, tRNA modification, autoimmune disease modulation, and synthetic methodology development. He has pioneered work on artificial nucleobase incorporation into tRNA, demonstrating disease remission in animal models of multiple sclerosis. His group designs bioactive heterocycles, including thiophenes, pyrrolidines, and piperidines, with applications in immunology and neuroscience.
The recent publications highlight a strong trend toward developing novel agents for autoimmune conditions such as rheumatoid arthritis and multiple sclerosis. These studies combine synthetic organic chemistry with biological evaluation, focusing on cytokine regulation (e.g., IL-6), tRNA modification enzymes, and neuroinflammatory pathways. The work bridges chemical synthesis and translational medicine, aiming to deliver new therapeutic strategies through nucleic acid and small molecule interventions.
Scientific Awards and Honors:
- Visiting Professor, University of Louvain-la-Neuve, Belgium (Jan–Apr 2006)
Dr. Southern has advised several graduate students and postdoctoral researchers, though specific names are not listed in the source material. His research has been supported by peer-reviewed grants, particularly in the areas of autoimmune disease therapeutics and nucleic acid chemistry, although grant details are not specified. He collaborates closely with researchers such as Prof. Stephen J. Connon and Prof. Vincent P. Kelly.
While no dedicated laboratory name is mentioned, his research group operates within the School of Chemistry at TCD, contributing to the institution’s strengths in pharmaceutical and synthetic chemistry. The team employs techniques in organic synthesis, enzymology, and molecular biology to explore novel biochemical interventions.
